Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective-Reference-Cited by-同舟云学术

Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective

Published:2013-09 Issue:1 Volume:58 Page:67-73
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Wesdorp D.J.W.,Knoester M.,Braat A.E.,Coenraad M.J.,Vossen A.C.T.M.,Claas E.C.J.,van Hoek B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference38 articles.

1. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease;Steinmuller;Hepatology,2002

2. Outcome of liver transplantation for hepatitis B in the United States;Kim;Liver Transpl,2004

3. Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis;Harrison;Histopathology,1993

4. Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation;Freeman;Transplantation,1991

5. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications;O’Grady;J Hepatol,1992

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

2. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation;Alimentary Pharmacology & Therapeutics;2021-07-19

3. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts;Liver International;2021-03-12

4. A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients;Transplantation Proceedings;2021-01

5. Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?;Annals of Transplantation;2020-03-31